T1	CHEM 59 102	vacuna antigripal tetravalente recombinante
T2	CHEM 104 108	RIV4
T3	LIVB 113 126	participantes
T4	Age 127 141	de 9 a 49 años
T5	PHYS 164 179	Inmunogenicidad
T6	CHEM 198 241	vacuna antigripal tetravalente recombinante
T7	CHEM 243 247	RIV4
T8	LIVB 252 257	niños
#1	AnnotatorNotes T8	C0008059; Child; Age Group | C0870221; Boys; Age Group
T9	Age 252 257	niños
T10	LIVB 260 272	adolescentes
#2	AnnotatorNotes T10	C0205653; Adolescent (age group); Age Group
T11	Age 260 272	adolescentes
T12	Age 273 287	de 9 a 17 años
T13	LIVB 290 297	adultos
#3	AnnotatorNotes T13	C0001675; Adult; Age Group
T14	Age 290 297	adultos
T15	Age 298 313	de 18 a 49 años
T16	DISO 337 342	Gripe
#4	AnnotatorNotes T16	C0021400; Influenza; Disease or Syndrome
T17	Age 377 391	de 9 a 49 años
T18	LIVB 423 435	participante
T19	Neg_cue 477 479	no
T20	PHYS 485 495	embarazada
#5	AnnotatorNotes T20	C0032961; Pregnancy; Organism Function
T21	Negated 485 495	embarazada
T22	PHYS 498 506	lactando
#6	AnnotatorNotes T22	C0006147; Breast Feeding; Organism Function
T23	Neg_cue 560 562	No
T24	PHYS 582 590	concebir
#7	AnnotatorNotes T24	C0009637; Conception; Organism Function
T25	Negated 582 590	concebir
T26	Neg_cue 618 620	no
T27	PHYS 640 648	concebir
#8	AnnotatorNotes T27	C0009637; Conception; Organism Function
T28	Negated 640 648	concebir
T29	LIVB 654 659	mujer
#9	AnnotatorNotes T29	C0043210; Woman; Population Group | C0242665; wife; Family Group
T30	PHYS 669 682	premenárquica
T31	PHYS 684 698	posmenopáusica
#10	AnnotatorNotes T31	C0206159; Postmenopause; Organism Function
T32	Duration 707 721	al menos 1 año
T33	PROC 744 769	esterilización quirúrgica
T34	PHYS 794 802	concebir
#11	AnnotatorNotes T34	C0009637; Conception; Organism Function
T35	PROC 820 841	método anticonceptivo
#12	AnnotatorNotes T35	C0700589; Contraceptive methods; Therapeutic or Preventive Procedure
T36	Duration 884 902	al menos 4 semanas
T37	PROC 923 937	administración
#13	AnnotatorNotes T37	C1533734; Administration procedure; Therapeutic or Preventive Procedure
T38	PROC 944 956	intervención
#14	AnnotatorNotes T38	C0184661; Interventional procedure; Therapeutic or Preventive Procedure
T39	Duration 975 997	por lo menos 4 semanas
T40	PROC 1019 1033	administración
#15	AnnotatorNotes T40	C1533734; Administration procedure; Therapeutic or Preventive Procedure
T41	PROC 1040 1052	intervención
#16	AnnotatorNotes T41	C0184661; Interventional procedure; Therapeutic or Preventive Procedure
T42	LIVB 1072 1084	participante
T43	PROC 1134 1158	consentimiento informado
#17	AnnotatorNotes T43	C0567423; Informed consent for procedure; Therapeutic or Preventive Procedure
T44	LIVB 1214 1219	padre
#18	AnnotatorNotes T44	C0015671; Father (person); Family Group | C0030551; parent; Family Group
T45	LIVB 1223 1228	madre
#19	AnnotatorNotes T45	C0026591; Mother (person); Family Group
T46	LIVB 1236 1255	representante legal
T47	PROC 1287 1311	consentimiento informado
#20	AnnotatorNotes T47	C0567423; Informed consent for procedure; Therapeutic or Preventive Procedure
T48	Neg_cue 1340 1351	Se excluirá
T49	LIVB 1370 1383	participantes
T50	Negated 1370 1383	participantes
T51	DISO 1435 1474	Inmunodeficiencia congénita o adquirida
T52	Spec_cue 1487 1497	sospechada
T53	PROC 1514 1538	terapia inmunosupresoras
T54	CHEM 1545 1558	quimioterapia
#21	AnnotatorNotes T54	C0013216; Pharmacotherapy; Therapeutic or Preventive Procedure | C0392920; Chemotherapy Regimen; Therapeutic or Preventive Procedure | C3665472; Chemotherapy; Therapeutic or Preventive Procedure
T55	PROC 1561 1587	radioterapia anticancerosa
T56	Duration 1592 1611	los últimos 6 meses
T57	PROC 1615 1649	terapia con corticoides sistémicos
T58	Date 1650 1664	de largo plazo
T59	CHEM 1666 1676	prednisona
#22	AnnotatorNotes T59	C0032952; prednisone; Hormone · Organic Chemical · Pharmacologic Substance
T60	Duration 1699 1728	más de 2 semanas consecutivas
T61	Duration 1732 1754	los 3 meses anteriores
T62	DISO 1760 1787	Hipersensibilidad sistémica
T63	CHEM 1835 1841	vacuna
#23	AnnotatorNotes T63	C0042210; Vaccines; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T64	DISO 1860 1870	reacciones
#24	AnnotatorNotes T64	C0221736; Reaction emotional; Finding
T65	PROC 1905 1919	administración
#25	AnnotatorNotes T65	C1533734; Administration procedure; Therapeutic or Preventive Procedure
T66	CHEM 1927 1934	vacunas
#26	AnnotatorNotes T66	C0042210; Vaccines; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T67	CHEM 1968 1974	vacuna
#27	AnnotatorNotes T67	C0042210; Vaccines; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T68	DISO 2027 2042	Trombocitopenia
#28	AnnotatorNotes T68	C0040034; Thrombocytopenia; Disease or Syndrome
T69	DISO 2047 2070	Trastornos hemorrágicos
#29	AnnotatorNotes T69	C0019087; Hemorrhagic Disorders; Disease or Syndrome
T70	PROC 2073 2087	administración
#30	AnnotatorNotes T70	C1533734; Administration procedure; Therapeutic or Preventive Procedure
T71	CHEM 2091 2106	anticoagulantes
#31	AnnotatorNotes T71	C0003280; Anticoagulants; Pharmacologic Substance
T72	Duration 2110 2123	las 3 semanas
T73	PROC 2188 2212	vacunación intramuscular
T74	Route 2199 2212	intramuscular
T75	LIVB 2235 2247	investigador
#32	AnnotatorNotes T75	C0035173; Research Personnel; Professional or Occupational Group
T76	DISO 2292 2318	síndrome de Guillain-Barré
#33	AnnotatorNotes T76	C0018378; Guillain-Barre Syndrome; Disease or Syndrome
T77	DISO 2320 2323	GBS
#34	AnnotatorNotes T77	C0018378; Guillain-Barre Syndrome; Disease or Syndrome
T78	DISO 2356 2405	retraso clínicamente significativo del desarrollo
T79	LIVB 2420 2432	investigador
#35	AnnotatorNotes T79	C0035173; Research Personnel; Professional or Occupational Group
T80	DISO 2438 2459	trastorno neurológico
#36	AnnotatorNotes T80	C0027765; nervous system disorder; Disease or Syndrome
T81	DISO 2465 2485	trastorno convulsivo
#37	AnnotatorNotes T81	C0014544; Epilepsy; Disease or Syndrome | C0234972; Convulsive disorder; Disease or Syndrome
T82	Neg_cue 2494 2496	no
T83	Negated 2548 2577	todos los aspectos relevantes
T84	Spec_cue 2586 2593	posible
T85	Speculated 2594 2607	participación
T86	LIVB 2614 2622	paciente
#38	AnnotatorNotes T86	C0030705; Patients; Patient or Disabled Group
T87	PROC 2629 2644	estudio clínico
#39	AnnotatorNotes T87	C0008972; Clinical Research; Research Activity | C0008976; Clinical Trials; Research Activity
T88	Negated 498 506	lactando
T89	PROC 864 875	abstinencia
T90	Speculated 1435 1474	Inmunodeficiencia congénita o adquirida
T91	Contraindicated 2188 2212	vacunación intramuscular
T92	Route 1639 1649	sistémicos
T93	CONC 405 414	inclusión
T94	Observation 436 473	cumple los requisitos para participar
T95	Quantifier_or_Qualifier 842 848	eficaz
T96	Observation 1116 1128	asentimiento
T97	Observation 1875 1900	pongan en peligro la vida
T98	CONC 2140 2149	inclusión
T99	Quantifier_or_Qualifier 2364 2390	clínicamente significativo
T100	Quantifier_or_Qualifier 2502 2510	previsto
T101	Observation 2594 2622	participación de un paciente
T102	Patient 113 126	participantes
T103	Patient 252 257	niños
T104	Patient 260 272	adolescentes
T105	Patient 290 297	adultos
T106	Patient 423 435	participante
T107	Patient 654 659	mujer
T108	History_of 744 769	esterilización quirúrgica
T109	Patient 1072 1084	participante
T110	Family_member 1214 1220	padre/
T111	Family_member 1223 1228	madre
T112	Other 1236 1255	representante legal
T113	Patient 1370 1383	participantes
T114	History_of 1435 1474	Inmunodeficiencia congénita o adquirida
T115	History_of 1514 1538	terapia inmunosupresoras
T116	History_of 1545 1558	quimioterapia
T117	History_of 1561 1587	radioterapia anticancerosa
T118	History_of 1615 1622	terapia
T119	History_of 1760 1787	Hipersensibilidad sistémica
T120	History_of 1860 1870	reacciones
T121	Other 2235 2247	investigador
T122	History_of 2356 2363	retraso
T123	History_of 2391 2405	del desarrollo
T124	Other 2420 2432	investigador
T125	History_of 2438 2459	trastorno neurológico
T126	History_of 2465 2485	trastorno convulsivo
T127	Future 2518 2529	información
T128	Patient 2614 2622	paciente
T129	Future 2637 2644	clínico
